Nasogastric tube placement was performed for (indication, e.g., enteral feeding, gastric decompression, medication administration).  Patient presented with (symptoms necessitating NG tube placement, e.g., dysphagia, nausea, vomiting, bowel obstruction).  Prior to insertion, patient identity was confirmed and the procedure explained, including risks and benefits.  Patient's nostrils were examined for patency and the appropriate NG tube size selected.  The distance to insert the tube was measured from the tip of the nose to the earlobe and then to the xiphoid process.  Lubricant was applied to the distal end of the NG tube.  The tube was advanced gently through the nare and into the nasopharynx.  Patient was instructed to swallow small sips of water or ice chips as the tube was advanced into the esophagus and stomach.  Upon reaching the estimated insertion depth, tube placement was confirmed by (method of verification, e.g., aspiration of gastric contents with pH testing, auscultation of air insufflation into the stomach, radiographic imaging).  Gastric aspirate pH was (pH value if obtained) and (description of aspirate, e.g., color, consistency).  (Amount, if applicable) mL of gastric content aspirated.  Breath sounds were auscultated to rule out tracheal placement.  The NG tube was secured at (location) with (type of securement device).  Patient tolerated the procedure well and was monitored for any immediate complications such as epistaxis, nausea, or respiratory distress.  Post-placement instructions for NG tube care and maintenance were provided.  Follow-up (plan, e.g., x-ray confirmation, feeding schedule).